We imagine a healthcare system where each patient’s journey is deeply informed by their whole-person context, including genomic, clinical, social, and protective risk factors.
2023 marked a pivotal moment, as we transitioned from developing our genomics program infrastructure to launching multiple early detection and precision therapy programs.
Read the reportWe believe healthcare should be personalized to each individual's needs and context, including the clinical, genomic, and social factors that contribute to shaping health outcomes. We work to ensure that genomic information is accessible and actionable for all patients and caregivers, and then we use our science engine to weave whole-person precision medicine into the very fabric of our care delivery.
Working across the continuum of prevention to treatment, and therapies, we turn today's most promising innovations into tomorrow's standard of care.
“Genomics has fundamentally transformed the clinical care of our oncology patients and is at the core of the innovations that will drive the future of personalized medicine.”
- Carlo Bifulco, MD
CMO, Providence Genomics and Associate Member, Translational Molecular Pathology, Earle A. Chiles Research Institute
"Precision prevention begins with knowing your risk. Besides the tremendous advances in identifying cancer risk and targeted treatment, the genome can provide insight into treating everything from depression to high cholesterol."
- Ora Karp Gordon, MD, MS, FACMG
Clinical Director, Providence Population Genomics Program, and Regional Director Southern California, Clinical Genetics and Genomics
"Genomics research is quickly transforming patient care, aiding those with diseases and those at risk. We're just beginning a remarkable journey where our current progress only scratches the surface of what's possible for us and our patients."
- Walter Urba, MD, PhD
Director, Providence Earle A. Chiles Research Institute, Robert W. Franz Cancer Center
“Genomics is fundamental to the future of personalized medicine and in the next decade will dramatically advance how we treat cancer.”
- Walter Urba, MD, PhD
Physician Executive for Research, Earle A. Chiles Research Institute; Chief Medical Officer, Providence
